378 related articles for article (PubMed ID: 10334384)
41. CD40 ligation inhibits IL-2 and SAC+IL-2 induced proliferation in chronic lymphocytic leukaemia cells.
Söderberg O; Christiansen I; Carlsson M; Nilsson K
Scand J Immunol; 1997 Jun; 45(6):706-14. PubMed ID: 9201312
[TBL] [Abstract][Full Text] [Related]
42. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.
Chaouchi N; Wallon C; Goujard C; Tertian G; Rudent A; Caput D; Ferrera P; Minty A; Vazquez A; Delfraissy JF
Blood; 1996 Feb; 87(3):1022-9. PubMed ID: 8562926
[TBL] [Abstract][Full Text] [Related]
43. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.
Ranheim EA; Cantwell MJ; Kipps TJ
Blood; 1995 Jun; 85(12):3556-65. PubMed ID: 7540066
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-4 (IL-4) inhibits proliferation and spontaneous cytokine release by chronic lymphocytic leukaemia cells.
Reittie JE; Hoffbrand AV
Leuk Res; 1994 Jan; 18(1):55-60. PubMed ID: 8289467
[TBL] [Abstract][Full Text] [Related]
45. Heterogeneous proliferative effect of tumor necrosis factor-alpha and lymphotoxin on mitogen-activated B cells from B-chronic lymphocytic leukemia.
Alvarez-Mon M; Garcia-Suarez J; Prieto A; Manzano L; Reyes E; Lorences C; Peraile G; Jorda J; Durantez A
Am J Hematol; 1993 Jun; 43(2):81-5. PubMed ID: 8342555
[TBL] [Abstract][Full Text] [Related]
46. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells.
Tangye SG; Weston KM; Raison RL
Leuk Lymphoma; 1998 Sep; 31(1-2):121-30. PubMed ID: 9720722
[TBL] [Abstract][Full Text] [Related]
47. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
Buhmann R; Nolte A; Westhaus D; Emmerich B; Hallek M
Blood; 1999 Mar; 93(6):1992-2002. PubMed ID: 10068672
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of type 4 cyclic nucleotide phosphodiesterase blocks intracellular TLR signaling in chronic lymphocytic leukemia and normal hematopoietic cells.
Tan Y; Watkins AA; Freeman BB; Meyers JA; Rifkin IR; Lerner A
J Immunol; 2015 Jan; 194(1):101-12. PubMed ID: 25416804
[TBL] [Abstract][Full Text] [Related]
49. Effects of type I/type II interferons and transforming growth factor-beta on B-cell differentiation and proliferation. Definition of costimulation and cytokine requirements for immunoglobulin synthesis and expression.
Estes DM; Tuo W; Brown WC; Goin J
Immunology; 1998 Dec; 95(4):604-11. PubMed ID: 9893052
[TBL] [Abstract][Full Text] [Related]
50. Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta.
Aderka D; Maor Y; Novick D; Engelmann H; Kahn Y; Levo Y; Wallach D; Revel M
Blood; 1993 Apr; 81(8):2076-84. PubMed ID: 8386026
[TBL] [Abstract][Full Text] [Related]
51. Cyclosporin A inhibits cytokine-induced proliferation in B-chronic lymphocytic leukemia.
Schmid M; Merk B; Porzsolt F
Leuk Lymphoma; 1994 Oct; 15(3-4):317-25. PubMed ID: 7866281
[TBL] [Abstract][Full Text] [Related]
52. The effect of cytokines on cultured mononuclear cells from patients with B cell chronic lymphocytic leukemia.
Burke F; Griffin D; Elwood N; Davis C; Stamp G; Rohatiner A; Lister TA; Balkwill F
Hematol Oncol; 1993; 11(1):23-33. PubMed ID: 8325624
[TBL] [Abstract][Full Text] [Related]
53. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
[TBL] [Abstract][Full Text] [Related]
54. Differences in IgE isotype switching induced by anti-CD40 monoclonal antibody and cytokines among subtypes of chronic B lymphoid leukemias.
Takeuchi H; Kayano H; Hirose T
Exp Hematol; 2000 May; 28(5):543-50. PubMed ID: 10812244
[TBL] [Abstract][Full Text] [Related]
55. T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cells.
Schmitter D; Koss M; Niederer E; Stahel RA; Pichert G
Hematol Oncol; 1997 Nov; 15(4):197-207. PubMed ID: 9722891
[TBL] [Abstract][Full Text] [Related]
56. Interleukin-15 + thioredoxin induce DNA synthesis in B-chronic lymphocytic leukemia cells but not in normal B cells.
Söderberg O; Christiansen I; Nilsson G; Carlsson M; Nilsson K
Leukemia; 1997 Aug; 11(8):1298-304. PubMed ID: 9264384
[TBL] [Abstract][Full Text] [Related]
57. Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine.
Wolska A; Cebula-Obrzut B; Smolewski P; Robak T
Leuk Lymphoma; 2013 Jun; 54(6):1268-78. PubMed ID: 23078646
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-4 inhibits both paracrine and autocrine tumor necrosis factor-alpha-induced proliferation of B chronic lymphocytic leukemia cells.
van Kooten C; Rensink I; Aarden L; van Oers R
Blood; 1992 Sep; 80(5):1299-306. PubMed ID: 1381243
[TBL] [Abstract][Full Text] [Related]
59. Alpha-interferon (alpha-IFN) protects B-chronic lymphocytic leukaemia cells from apoptotic cell death in vitro.
Panayiotidis P; Ganeshaguru K; Jabbar SA; Hoffbrand AV
Br J Haematol; 1994 Jan; 86(1):169-73. PubMed ID: 8011526
[TBL] [Abstract][Full Text] [Related]
60. Cytokines and cross-linking of sIgM augment PMA-induced activation of human leukaemic CD5+ B cells.
Tangye SG; Weston KM; Raison RL
Immunol Cell Biol; 1997 Dec; 75(6):561-7. PubMed ID: 9492192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
